Medicare Coverage for Multi-Cancer Early Detection Screening Tests.
This legislation mandates Medicare coverage for advanced multi-cancer early detection screening tests, ensuring beneficiaries gain access to these potentially life-saving diagnostics. Once approved by the FDA, tests like genomic sequencing blood tests will be covered, aiming to significantly improve early diagnosis across various cancer types. This change expands healthcare options for millions of seniors.
Key points
Medicare Part B will cover the cost of new multi-cancer early detection screening tests.
Coverage applies only to tests that have been approved or cleared by the Food and Drug Administration (FDA).
Beneficiaries are limited to receiving this specific screening test once every 11 months.
Expired
Citizen Poll